Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

LRF Haemato-oncology Group

Nuffield Department of Clinical Laboratory Sciences

University of Oxford

John Radcliffe Hospital

Name/email consistency: high

LRF Haemato-oncology Group, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, UK. 2006 - 2009
University of Oxford, John Radcliffe Hospital, Nuffield Department of Clinical Laboratory Sciences, Headington, UK. 2009
Leukemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, United Kingdom. 2005

Monoclonal antibodies raised to the human FOXP3 protein can be used effectively for detecting Foxp3(+) T cells in other mammalian species. Banham, A.H., Lyne, L., Scase, T.J., Blacklaws, B.A. Vet. Immunol. Immunopathol. (2009) [Pubmed]
Therapeutic targeting of FOXP3-positive regulatory T cells using a FOXP3 peptide vaccine WO2008081581. Banham, A.H., Pulford, K. Expert. Opin. Ther. Pat (2009) [Pubmed]
Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells. Banham, A.H. Trends Immunol. (2006) [Pubmed]
FOXP3+ regulatory T cells: Current controversies and future perspectives. Banham, A.H., Powrie, F.M., Suri-Payer, E. Eur. J. Immunol. (2006) [Pubmed]
Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma. Banham, A.H., Connors, J.M., Brown, P.J., Cordell, J.L., Ott, G., Sreenivasan, G., Farinha, P., Horsman, D.E., Gascoyne, R.D. Clin. Cancer Res. (2005) [Pubmed]